Diamond Shruumz, the Willy Wonka of the psychedelic snack world, just got their golden ticket revoked after their chocolate and gummies allegedly sent 113 people on an unplanned trip to the ER across 28 states, with 42 VIP hospital stays. The mystery illness menu featured seizures, vomiting, and respiratory failure, leaving experts scratching their heads and conspiracy theorists pointing fingers at psychedelics.
This recall has crackled up debates around 4-AcO-DMT, the sketchy cousin of psilocybin often moonlighting in “magic blend” products at smoke shops. Notorious for being cheaper and easier to whip up than traditional shrooms, it’s sparked a turf war with old-school mushroom growers. Cue the déjà vu from the 2019 vaping scare, a not-so-gentle reminder of the perils of unregulated goodies and the media’s love for a juicy panic story.
Recent sensational headlines about microdosing mushroom chocolate bars causing illnesses have muddied the waters further, suggesting poisoning when the real culprits might be foodborne nasties or dodgy solvents from back-alley production lines. The media, hungry for clicks, skips over the lack of solid evidence linking the symptoms to substances like psilocin, 4-AcO, or even kava.
Industry whispers hint at serotonin syndrome following a formula tweak, but with a massive batch and relatively few cases, the plot thickens. The bottom line? We need less alarmist spin and more solid consumer education and regulation to prevent snack-time from turning into a medical mystery tour.
Published Date: 2024-09-11